J 2019

ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer

ESTEBAN-GIL, Angel, Fernando PEREZ-SANZ, Jose GARCIA-SOLANO, Begona ALBURQUERQUE-GONZALEZ, Maria PARRENO-GONZALEZ et. al.

Basic information

Original name

ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer

Authors

ESTEBAN-GIL, Angel (724 Spain, guarantor), Fernando PEREZ-SANZ (724 Spain), Jose GARCIA-SOLANO (724 Spain), Begona ALBURQUERQUE-GONZALEZ (724 Spain), Maria PARRENO-GONZALEZ (724 Spain), Maria del Carmen LEGAZ-GARCIA (724 Spain), Jesualdo Tomas FERNANDEZ-BREIS (724 Spain), Edith RODRIGUEZ-BRAUN (724 Spain), Paola PIMENTEL (724 Spain), Anne TUOMISTO (246 Finland), Markus MAKINEN (246 Finland), Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Pablo CONESA-ZAMORA (724 Spain)

Edition

SCIENTIFIC DATA, LONDON, NATURE PUBLISHING GROUP, 2019, 2052-4463

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.541

RIV identification code

RIV/00216224:14740/19:00112508

Organization unit

Central European Institute of Technology

UT WoS

000494480700001

Keywords in English

MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; SERRATED POLYPS; COLON-CANCER; PHENOTYPE; CARCINOGENESIS; ADENOCARCINOMA; BIOMARKERS; PATHWAYS; GENES

Tags

International impact, Reviewed
Změněno: 26/2/2020 12:38, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Colorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbiota and altered microRNA expression in CRC carcinogenesis, but their relationship with pathological drivers or molecular phenotypes is not clearly established. Joint analysis of clinical and omics data can help clarify such relations. We present ColPortal, a platform that integrates transcriptomic, microtranscriptomic, methylomic and microbiota data of patients with colorectal cancer. ColPortal also includes detailed information of histological features and digital histological slides from the study cases, since histology is a morphological manifestation of a complex molecular change. The current cohort consists of Caucasian patients from Europe. For each patient, demographic information, location, histology, tumor staging, tissue prognostic factors, molecular biomarker status and clinical outcomes are integrated with omics data. ColPortal allows one to perform multiomics analyses for groups of patients selected by their clinical data.